IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.962
EU - Europa 6.579
AS - Asia 6.319
SA - Sud America 808
AF - Africa 96
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
Totale 22.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.774
SG - Singapore 2.552
CN - Cina 1.733
RU - Federazione Russa 1.379
UA - Ucraina 914
IE - Irlanda 888
SE - Svezia 781
IT - Italia 681
BR - Brasile 672
TR - Turchia 645
GB - Regno Unito 624
VN - Vietnam 581
DE - Germania 423
FR - Francia 395
IN - India 285
FI - Finlandia 213
HK - Hong Kong 118
CA - Canada 111
BD - Bangladesh 68
AR - Argentina 59
MX - Messico 58
PL - Polonia 56
JP - Giappone 48
ES - Italia 42
BE - Belgio 40
IQ - Iraq 39
NL - Olanda 35
ZA - Sudafrica 34
SA - Arabia Saudita 33
EC - Ecuador 28
KR - Corea 27
TW - Taiwan 25
AT - Austria 23
ID - Indonesia 22
AU - Australia 19
JO - Giordania 17
PK - Pakistan 15
CZ - Repubblica Ceca 14
KE - Kenya 14
UZ - Uzbekistan 14
VE - Venezuela 13
GR - Grecia 12
IL - Israele 12
LT - Lituania 12
EU - Europa 11
IR - Iran 11
RO - Romania 10
CO - Colombia 9
EG - Egitto 9
PY - Paraguay 9
TN - Tunisia 9
MA - Marocco 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
MY - Malesia 6
NP - Nepal 6
BO - Bolivia 5
CL - Cile 5
DZ - Algeria 5
LB - Libano 5
OM - Oman 5
PS - Palestinian Territory 5
TH - Thailandia 5
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
NO - Norvegia 4
PE - Perù 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
AO - Angola 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CU - Cuba 2
HU - Ungheria 2
LK - Sri Lanka 2
LY - Libia 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
Totale 22.777
Salva come PNG Salva come JPEG
Città #
Singapore 1.908
Chandler 1.099
Jacksonville 1.041
San Jose 947
Dublin 871
Ashburn 595
Princeton 437
Beijing 415
Southend 385
Dallas 337
Izmir 327
Nanjing 291
Dearborn 247
Wilmington 222
Los Angeles 219
Ho Chi Minh City 211
Santa Clara 207
Cambridge 170
The Dalles 149
Altamura 138
Ann Arbor 131
Chieti 130
Hanoi 129
Tongling 128
Hong Kong 106
New York 106
Buffalo 104
Nanchang 98
São Paulo 90
Boardman 81
Munich 81
Woodbridge 81
Moscow 78
Hebei 65
Council Bluffs 58
Shenyang 54
Houston 49
Kunming 49
Redondo Beach 45
Jiaxing 43
Tianjin 43
Helsinki 41
Tokyo 41
Washington 35
Hefei 33
Warsaw 33
Brussels 32
Grevenbroich 32
Montreal 30
Pescara 30
Brooklyn 28
Changsha 28
Hangzhou 28
San Mateo 28
Chennai 27
Poplar 27
Seattle 27
Stockholm 27
Denver 26
Milan 26
Riyadh 26
Norwalk 25
Da Nang 24
Falls Church 24
Orem 24
Toronto 24
Haiphong 23
Rio de Janeiro 23
Atlanta 22
Boston 22
Jinan 22
Guangzhou 21
Phoenix 21
San Francisco 21
Augusta 20
Leawood 20
Nuremberg 20
Amsterdam 19
Chicago 19
Johannesburg 19
Baghdad 18
Dhaka 16
London 16
Mexico City 16
Orange 16
Amman 15
Ankara 15
Frankfurt am Main 15
Manchester 15
Rome 15
Belo Horizonte 14
Biên Hòa 14
Dong Ket 14
Mumbai 14
Nairobi 14
Ningbo 14
Porto Alegre 14
Querétaro 14
Seoul 14
Taipei 14
Totale 13.280
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 824
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 317
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 240
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 170
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 165
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 164
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 162
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 158
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 155
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 154
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 150
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 148
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 143
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 142
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 140
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 139
Apixaban for extended treatment of venous thromboembolism 138
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 137
Circulating leptin is associated with oxidized LDL in postmenopausal women. 137
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 136
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 136
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 134
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 133
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 133
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 132
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 132
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 132
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 130
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 130
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 130
Oral rivaroxaban for symptomatic venous thromboembolism 130
[Physiopathological bases of the medical treatment of portal hypertension]. 129
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 129
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 128
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 127
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 126
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 126
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 126
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 126
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 126
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 125
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 125
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 125
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 124
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 124
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 124
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 123
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 123
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 123
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 122
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 122
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients 122
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 121
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 121
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 120
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 120
Oral apixaban for the treatment of acute venous thromboembolism 120
Evidence for oxidative and not reductive stress in the aged rabbit heart 120
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 120
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 119
Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients. 119
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 119
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 119
Non-O blood group and outcomes of in vitro fertilization 119
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 118
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 117
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 117
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 117
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 117
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 117
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 116
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 116
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 115
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 115
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 114
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 114
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 114
Altered doppler left ventricular (LV) diastolic function induced by handgrip in mild hypertensives with normal LV mass 114
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 114
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 113
Determinants of platelet activation in Alzheimer's disease 113
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 113
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 112
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 112
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 111
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 111
Systemic oxidative stress status in patients with ischemic heart disease 111
Rivaroxaban for cancer-associated cardiac thrombosis 111
Effects of body composition on the procoagulant imbalance in obese patients 111
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 110
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 110
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 110
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 109
Effect of aortic coarctation hypertension on the antioxidant defense mechanisms in the rabbit aorta 108
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 108
Iron status and oxidative stress in the aged rabbit heart 108
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 108
Inhibition of P-glycoprotein mediated transport by S-adenosylmethionine and Cynarin in multidrug resistant human uterine sarcoma MES-SA/Dx5 cells. 107
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 107
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 106
Totale 13.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 0 0 0 0 163 79 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20253.640 241 625 537 56 65 138 90 175 401 223 461 628
2025/20267.563 660 375 686 887 721 523 1.260 486 1.452 513 0 0
Totale 23.372